Leila Alland - 15 Sep 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Medical Officer
Signature
/s/ Winston Kung, by power of attorney
Issuer symbol
PMVP
Transactions as of
15 Sep 2023
Net transactions value
-$41,646
Form type
4
Filing time
18 Sep 2023, 16:22:58 UTC
Previous filing
16 Jun 2023
Next filing
29 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Sale $41,646 -6,291 -12% $6.62 45,909 15 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.